We believe strong fundamentals as scientists and strategic problem solvers drive sound recommendations across a diverse set of clients, products, and markets. Our project portfolio in pharma and biotech strategy is expansive. Our capabilities span all stages of the product lifecycle — from early-stage opportunity assessments to inform where a product’s greatest value may lie, to comprehensive launch planning and support. We additionally support clients in setting strategy at the franchise and corporate level — including therapeutic area strategy, licensing and acquisitions, and corporate growth strategy. We have worked in every therapeutic area, and in both developed and emerging markets. We work with organizations big and small, from top ten pharma companies to early startups. While the solutions should be right sized for the organization, our commitment to an exceptional project experience applies to all. We are solving the problems at new frontiers for pharma. Below, explore a few examples that spotlight our recent work. Pipeline Discovery & Development MOA Mapping and Prioritization Pipeline Optimization Indication Prioritization Product Profile Development Opportunity Assessment Patient Journey Assessment Brand Launch & Lifecycle Strategy Demand Assessment Patient & Prescriber Segmentation Revenue Forecasting Go-to-market Strategy Global Launch Sequencing Lifecycle Management Therapeutic Area & Corporate Strategy Therapeutic Area Assessment Portfolio Strategy Competitive Intelligence Corporate Growth Strategy Asset Screening and Diligence Buy- and Sell-side Due Diligence

Combining data science with scientific and commercial expertise to incorporate analytical rigor into strategic problem-solving for life sciences clients. Delivers analytics-driven engagements that help clients draw key business implications from complex data sources, supporting novel analytics methods for market sizing and targeting strategies in non-traditional healthcare markets. Leverages proprietary analytics capabilities and deep life sciences domain expertise to transform raw data into strategic insights, enabling data-driven decision-making across corporate strategy, product positioning, and market opportunity assessment.

Customized primary market research services — including KOL interviews, payer research, surveys, and focus groups — supported by a world-class network of 5,000+ experts across 45+ therapeutic areas. Conducted more than 8,000 interviews in 2018 alone, with expert coverage in over 40 geographies spanning all major established and emerging markets. Range of research methods from telephone interviews to surveys, in-person interviews, multi-stakeholder interviews, and web-based focus groups enables nuanced understanding of key stakeholder perspectives — clinicians, payers, patients, and market participants — critical for strategic and commercial decision-making in life sciences.

Deep industry expertise and data-driven analysis to provide differentiated strategic support for investors in the life sciences and healthcare sectors. Combines deep industry expertise with data-driven analysis to support investors in Life Sciences and Healthcare through consulting services for strategic decision-making and growth. Capabilities encompass diligence activities and opportunity assessments for life sciences investors, enabling investment committee support, portfolio strategy guidance, and value creation planning across acquisition and organic growth initiatives.

End-to-end support across all aspects of product launch — from launch strategy through execution and post-launch performance optimization — for life sciences companies. Helps clients understand the market, build capabilities, develop a winning launch strategy, and optimize post-launch brand trajectory. Tailored offerings address multiple aspects of launch spanning strategy, execution, and post-launch performance. Comprehensive engagements guide clients from market entry planning through commercial execution and sustained market performance management, ensuring alignment between strategic intent and operational capability across the full product lifecycle.

Strategy consulting for medical device, diagnostics, and digital health companies, covering opportunity assessments, commercialization and reimbursement strategies, and global market entry. Delivers pricing and market access assessments that evaluate reimbursement paths and payer value drivers, supporting strategic direction for technology and business units. Experience spans different medical technologies with capabilities in opportunity assessments, diligence activities, and strategic positioning for digital therapeutics and emerging health technologies in both established and emerging markets.

Strategic consulting spanning all stages of the pharmaceutical and biotech product lifecycle — from early-stage opportunity assessments and therapeutic area strategy to licensing, acquisitions, and corporate growth strategy. Supports companies of all sizes across all therapeutic areas, helping biotechs transition from single-product companies to marketed franchises with strong pipelines. Capabilities encompass Phase 1 through global launch and lifecycle planning, with strategic support for corporate development decisions, business unit positioning, and portfolio optimization across the full spectrum of pharmaceutical and biotech business models.

Developing clear and effective pricing, access, and value-and-evidence strategies at the product, franchise, and corporate level across all major and emerging global markets. Provides strategic support in launch price setting, competitive entry strategy, contracting strategy, and evidence generation strategies across key markets, clarifying price/volume trade-off assumptions for pipeline assets. Deliversdefensible pricing and access strategies that integrate commercial and clinical evidence, enabling clients to navigate complex reimbursement landscapes and optimize value capture across diverse global market conditions.